CVD Equipment (NasdaqCM:CVV) Q4 2025 Earnings call March 30, 2026 05:00 PM ET Company ParticipantsBrett Reiss - SVP of Investments and Financial AdvisorEmmanuel Lakios - President and CEORichard Catalano - EVP and CFOConference Call ParticipantsNone - AnalystOperatorGood afternoon, and welcome to the CVD Equipment Corporation fourth quarter and full year 2025 earnings conference call. As a reminder, today's call is being recorded. We will begin with prepared remarks, followed by a question-and-answer sessio ...

CVD Equipment (NasdaqCM:CVV) Q4 2025 Earnings call March 30, 2026 05:00 PM ET Speaker3Good afternoon, and welcome to the CVD Equipment Corporation fourth quarter and full year 2025 earnings conference call. As a reminder, today's call is being recorded. We will begin with prepared remarks, followed by a question-and-answer session. Presenting on today's call are Emmanuel Lakios, President and Chief Executive Officer, and Richard Catalano, Executive Vice President and Chief Financial Officer. Our earnings pr ...

ARKO Petroleum (NasdaqCM:APC) Q4 2025 Earnings call March 30, 2026 05:00 PM ET Speaker3Greetings, and welcome to the ARKO Petroleum Corp. fourth quarter and full year 2025 financial results. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Jordan Mann, Vic ...

Phreesia (NYSE:PHR) Q4 2026 Earnings call March 30, 2026 05:00 PM ET Speaker12Good evening, ladies and gentlemen, and welcome to the Phreesia fourth quarter fiscal 2026 earnings conference call. At this time, all participants are in a listen-only mode. We will provide instructions for the question-and-answer session to follow. First, I would like to introduce Balaji Gandhi, Phreesia's Chief Financial Officer. Mr. Gandhi, you may begin.Speaker0Thank you, operator. Good evening, and welcome to Phreesia's earn ...

zSpace (NasdaqGM:ZSPC) Q4 2025 Earnings call March 30, 2026 05:00 PM ET Speaker3Hello, and thank you for participating in today's conference call to discuss zSpace's financial results for the fourth quarter and full year ended December 31, 2025. Joining us today are zSpace Chief Executive Officer, Paul Kellenberger, Chief Financial Officer, Erick DeOliveira, and Greg Robles from Investor Relations. Following their remarks, we'll open the call for analyst questions. Before we go further, I would like to turn ...

Spruce Power (NYSE:SPRU) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsChris Hayes - CEOJulia Cassari - Head of Corporate Development and Investor RelationsTom Cimino - CFOWill Hamilton - Partner and Portfolio Manager of Kestrel Phoenix FundOperatorI'd like to welcome everyone to the Spruce Power fourth quarter 2025 earnings results conference call. All lines have been placed on mute to prevent any background noise. If you'd like to ask a question during the question and answer sessio ...

Sangamo Therapeutics (NasdaqCM:SGMO) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsCassie Yuan - Biotechnology Equity Research AssociateJames Heaney - Equity Research AssociateLouise Wilkie - Head of Investor Relations and Corporate CommunicationsLuis Santos - Senior Equity Research AssociateNathalie Dubois-Stringfellow - Chief Development OfficerSandy Macrae - CEOOperatorGood afternoon, and welcome to the Sangamo Therapeutics fourth quarter and full year 2025 teleconference call. Ple ...

Sangamo Therapeutics (NasdaqCM:SGMO) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsCassie Yuan - Biotechnology Equity Research AssociateJames Heaney - Equity Research SVPLouise Wilkie - Head of Investor Relations and Corporate CommunicationsLuis Santos - Senior Equity Research AssociateNathalie Dubois-Stringfellow - Chief Development OfficerSandy Macrae - CEOOperatorGood afternoon, and welcome to the Sangamo Therapeutics fourth quarter and full year 2025 teleconference call. Please be ...

Intellinetics (NYSEAM:INLX) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsAlison Forsythe - President and CEOJoe Spain - CFORoger Grabner - Director of MarketingOperatorGood evening, and welcome to the Intellinetics fourth quarter and full year 2025 earnings conference call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. You may be placed in the question queue at any time by pressing star one on your telephone ...

INmune Bio (NasdaqCM:INMB) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsCJ Barnum - Head of NeuroscienceCory Ellspermann - Interim CFODaniel Carlson - Head of Investor RelationsDavid Moss - CEO and Co-FounderElemer Piros - Managing DirectorMark Lowdell - Chief Scientific Officer and Co-FounderOperatorGreetings, and welcome to the INmune Bio's 2025 fourth quarter and year-end earnings call. As a reminder, this conference is being recorded. A transcript will follow within 24 hours of t ...